Aeglea BioTherapeutics



Aeglea BioTherapeutics produces engineered human enzymes for cancer and rare genetic diseases. Click to find out more about our enzyme therapy research.

Leslie Sloan
Chief Operating Officer
Michael C. Hanley
Chief Commercial Officer
Scott W. Rowlinson
VP of Research
Steven Weber
VP & Principal Accounting Officer
Eric Bradford
Chief Development Officer
Eugene Sackett
VP of HR

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.